Celularity Stock Technical Analysis
| CELU Stock | USD 1.20 0.03 2.44% |
As of the 5th of February, Celularity shows the Risk Adjusted Performance of (0.07), standard deviation of 5.08, and Mean Deviation of 3.6. Celularity technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Celularity Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Celularity, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to CelularityCelularity | Build AI portfolio with Celularity Stock |
Celularity Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 2.5 | Buy | 1 | Odds |
Most Celularity analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Celularity stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Celularity, talking to its executives and customers, or listening to Celularity conference calls.
Is there potential for Biotechnology market expansion? Will Celularity introduce new products? Factors like these will boost the valuation of Celularity. Projected growth potential of Celularity fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Celularity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.61) | Earnings Share (3.33) | Revenue Per Share | Quarterly Revenue Growth (0.43) | Return On Assets |
The market value of Celularity is measured differently than its book value, which is the value of Celularity that is recorded on the company's balance sheet. Investors also form their own opinion of Celularity's value that differs from its market value or its book value, called intrinsic value, which is Celularity's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Celularity's market value can be influenced by many factors that don't directly affect Celularity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Celularity's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Celularity should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Celularity's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Celularity 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Celularity's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Celularity.
| 11/07/2025 |
| 02/05/2026 |
If you would invest 0.00 in Celularity on November 7, 2025 and sell it all today you would earn a total of 0.00 from holding Celularity or generate 0.0% return on investment in Celularity over 90 days. Celularity is related to or competes with Bioatla, Reviva Pharmaceuticals, Annovis Bio, Actinium Pharmaceuticals, BioXcel Therapeutics, Kezar Life, and PolyPid. Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therap... More
Celularity Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Celularity's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Celularity upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.12) | |||
| Maximum Drawdown | 26.97 | |||
| Value At Risk | (8.97) | |||
| Potential Upside | 9.01 |
Celularity Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Celularity's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Celularity's standard deviation. In reality, there are many statistical measures that can use Celularity historical prices to predict the future Celularity's volatility.| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.63) | |||
| Total Risk Alpha | (0.95) | |||
| Treynor Ratio | (0.56) |
Celularity February 5, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | (0.55) | |||
| Mean Deviation | 3.6 | |||
| Coefficient Of Variation | (906.18) | |||
| Standard Deviation | 5.08 | |||
| Variance | 25.77 | |||
| Information Ratio | (0.12) | |||
| Jensen Alpha | (0.63) | |||
| Total Risk Alpha | (0.95) | |||
| Treynor Ratio | (0.56) | |||
| Maximum Drawdown | 26.97 | |||
| Value At Risk | (8.97) | |||
| Potential Upside | 9.01 | |||
| Skewness | 0.615 | |||
| Kurtosis | 2.27 |
Celularity Backtested Returns
Celularity secures Sharpe Ratio (or Efficiency) of -0.11, which signifies that the company had a -0.11 % return per unit of risk over the last 3 months. Celularity exposes twenty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Celularity's Risk Adjusted Performance of (0.07), standard deviation of 5.08, and Mean Deviation of 3.6 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.02, which signifies a somewhat significant risk relative to the market. Celularity returns are very sensitive to returns on the market. As the market goes up or down, Celularity is expected to follow. At this point, Celularity has a negative expected return of -0.54%. Please make sure to confirm Celularity's standard deviation, value at risk, as well as the relationship between the Value At Risk and day median price , to decide if Celularity performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.59 |
Modest predictability
Celularity has modest predictability. Overlapping area represents the amount of predictability between Celularity time series from 7th of November 2025 to 22nd of December 2025 and 22nd of December 2025 to 5th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Celularity price movement. The serial correlation of 0.59 indicates that roughly 59.0% of current Celularity price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.59 | |
| Spearman Rank Test | -0.17 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Celularity technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Celularity Technical Analysis
The output start index for this execution was fifty with a total number of output elements of eleven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Celularity volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Celularity Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Celularity on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Celularity based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Celularity price pattern first instead of the macroeconomic environment surrounding Celularity. By analyzing Celularity's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Celularity's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Celularity specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Payables Turnover | 1.13 | 0.64 | 0.74 | 0.7 | Days Of Inventory On Hand | 131.11 | 131.72 | 151.47 | 218.55 |
Celularity February 5, 2026 Technical Indicators
Most technical analysis of Celularity help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Celularity from various momentum indicators to cycle indicators. When you analyze Celularity charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | (0.55) | |||
| Mean Deviation | 3.6 | |||
| Coefficient Of Variation | (906.18) | |||
| Standard Deviation | 5.08 | |||
| Variance | 25.77 | |||
| Information Ratio | (0.12) | |||
| Jensen Alpha | (0.63) | |||
| Total Risk Alpha | (0.95) | |||
| Treynor Ratio | (0.56) | |||
| Maximum Drawdown | 26.97 | |||
| Value At Risk | (8.97) | |||
| Potential Upside | 9.01 | |||
| Skewness | 0.615 | |||
| Kurtosis | 2.27 |
Celularity February 5, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Celularity stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.00 | ||
| Daily Balance Of Power | (Huge) | ||
| Rate Of Daily Change | 0.98 | ||
| Day Median Price | 1.20 | ||
| Day Typical Price | 1.20 | ||
| Price Action Indicator | (0.02) |
Additional Tools for Celularity Stock Analysis
When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.